Kriston Toxeamia irodalomjegyzék

Irodalomjegyzék:

1. Lampé L, Papp Z: Szülészet-nogyógyászat

1992. Semmelweis Kiadó, Budapest, 50-58.

2. Lapis K: Pathologia

1989. Medicina Kiadó, Budapest, 962-63.

3. MSD Orvosi Kézikönyv, The Merck Manual

1994. Melánia Kiadó Kft. Budapest, 1870-71.

4. L. M. Tierney, S. J. McPhee, M. A. Papadakis:

Korszeru orvosi diagnosztika és terápia

1996. Melánia Kiadó Kft, Budapest, 678-680.

5. Lintner F, Pajor A:

Szülészet-nogyógyászat

1994. Springer Hung. Kiadó Kft.

6. Mezody M, Diószeghy Cs, Pénzes I:

HELLP-syndroma, a terhességi toxicosis különleges formája

Orvosi Hetilap 1995. 50. 2733-36.

7. F. Broughton Pipkin, P. C.:

Pre-eclampsia - the diseases of theories

Br Med Bull 1994. 2. 381-96.

8. B.M. Sibai, M. Ewell, R.J. Levine, M.A. Klebanoff, J. Esterlitz, P.M. Catalano, R.L. Goldenberg, G. Joffe:

Risk factors associated with preeclampsia in healthy nulliparous women

Am J Obstet Gynecol 1997. 177. 1003-10.

9. A. Witlin, B.M. Sibai:

Hypertension in pregnancy: Current concepts of preeclampsia

Annu. Rev. Med. 1997. 48.115-27.

10. C. van Oppen, I. van der Tweel, G. P. J. Alsbach, R.M. Heethaar, H. W. Bruinse:

A logitudinal study of maternal hemodynamics during normal pregnancy

Obstet Gynecol 1996. 88. 40-6.

11. G. Söder, C. Grenroth, L.-O. Norée and P.E. Wiklund:

Treatment of pre-eclamsia and eclampsia as a hypoperfusion syndrome

Acta Anaesth Scand 1975. Suppl. 57. 71-78.

12. F. G. Cunningham, M. D. Lindheimer:

Hypertension in pregnancy

N Engl J Med 1992. 326. 927-32.

13. J. Young:

The eathiology of eclamsia and albuminuria and their relation to accidental hemorrhage

J Obstet Gynecol Br Empire 1914. 26. 1-5.

14. E. Ogden, G.J. Hildebrand, E. W. Page:

Rise of blood pressure during ischemia of gravid uterus

Proc Soc Exp Biol Med 1940. 43. 49-51.

15. I. Brosens:

A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies

J Obstet Gynecol Brit Common 1964. 71. 222-30.

16. M.M. Abitbol, C. L. Pirani, W. B. Ober et al:

Production of experimental toxemia in the pregnant dog

Obstet Gynecol 1976. 48. 537-48.

17. K.E. Clark, M. Durnwald, J. E. Austin:

A model for studying chronic reduction in uterine blood flow in pregnant sheep

Am J Physiol 1982. 242. H297-H301.

18. Losonczy Gy, Mucha I:

Potentiation of reduced uteroplacental perfusion pressure hypertension in pregnant rabbits

Hypertension in Preg 1993. 12. 475-85.

19. Losonczy Gy, G. Brown, R. C. Venuto:

Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits

Am J Med Sci 1992. 303. 233-40.

20. F. P. Zuspan:

Abnormal placentation in hypertensive disorders of pregnancy

Hypertension: Pathophysiology, Diagnosis and Management, edited by J. H. Laragh and B. M. Brenner. Raven Press Ltd. New York 1990. 1779-88.

21. R. B. Ness, J. M. Roberts:

Heterogenous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications

Am J Obstet Gynecol 1996. 175. 1365-70.

22. T. F. Ferris:

Toxemia of pregnancy: A model of human hypertension

Cardiovascular Medicine 1977. 9. 877-97.

23. B. Langer, M. Grima, C. Coquard, A. Bader, G. Schlaeder J.-L. Imbs:

Plasma active renin, angiotensin I and angiotensin II during pregnancy and in preeclampsia

Obstet Gynecol 1998. 91. 196-202.

24. S. W. Graves, T. J. Moore, E. W. Seely:

Increased platelet angiotensin II receptor number in pregnancy-induced hypertension

Hypertension 1992. 20. 627-32.

25. I. Massé, J.-C. Forest, J.-M. Moutquin, P. Degrandpré, V. I. Forest:

A prospective longitudinal study of platelet angiotensin II receptors for the prediction of preeclampsia

Clinical Biochemistry 1998. 31. 251-55.

26. I. Ward, A. O`Hata, X. Jeunemaitre et al:

A molecular variant of angiotensinogen associated with preeclampsia

Nature Genet 1993. 4. 59-61.

27. S. Jeunemaitre, F. Soubrier, Y. V. Kotelevtsev et al:

Molecular basis of hypertension: Role of angiotensinogen

Cell 1992. 71. 169-80.

28. A. Johenning, M. D. Lindheimer:

Hypertension in pregnancy

Current Opinion in Nephrology and Hypertension 1993. 2. 307-313.

29. J. Fitzgerald, G. A. Fitzgerald:

Eicosanoids in the pathogenesis of preeclampsia

Hypertension: Pathophysiology, Diagnosis and Management, edited by J. H. Laragh and B. M. Brenner, Raven Press Ltd, New York 1990. 1789-1807.

30. A. E. Meagher G. A. Fitzgerald:

Disordered eicosanoid formation in prenancy-induced hypertension

Circulation 1993. 88. 1324-33.

31. S. Walsh, Y. Wang:

Deficient glutathione peroxidase activity in preeclampsia is assiciated with increased placental production of thromboxane and lipid peroxides

Am J Obstet Gynecol 1993. 169. 1456-61.

32. Liel, I. Nathan, T. Yermiyahu, Z. Zolotov, J. R. Lieberman, A. Dvilansky, P. V. Halushka: Increased platelet thromboxane A_{2/prostaglandin H2 receptors in patients with
pregnancy-induced hypertension}

_{Thrombosis Res 1993. 70. 205-10.

33. M. J. Fitzgerald, W. Rocki, R. Murray, G. Mayo,
G. A. Fitzgerald:

Thromboxane A2 synthesis in prenancy-induced
hypertension

Lancet 1990. 335. 751-54.

34. G. A. Fitzgerald, C. Healy, J. Daugherty:

Thromboxane A2 biosynthesis in human disease

Fedreration Proc 1987. 46. 154-58.

35. G. C. Renzo, G. Coata, s. Franceschi, E.
Chiaradia, A. Kett, R. Vezza, G. G. Nenci, E. V. Cosmi, P. Gresele:

Platelet thromboxane A2 receptor number and function
in normal and hypertensive pregnancy

AJRI 1993. 30. 160-66.

36. Losonczy Gy, J.P. Singh, M. Schoenl, Mucha I, R.
Venuto:

Pregnancy enhances the pressor response to
thromboxane analogues in rabbits

Am J Physiol 1995. 269. R720-25.

37. Losonczy Gy, Mucha I, J. DiPirro, J. Sweeney, G.
Brown, J. Brentjens, R. Venuto:

The effect of pregnancy on the response to the
TXA2/PGH2 analogue U 46 619 in rabbits

Am J Physiol 1993. 265. R772-780.

38. Losonczy Gy, G. Brown, Mucha I, R. Klocke et al:

Gestational resistance to the pulmonary
vasoconstrictor effect of the TXA2 mimetic U 46 619: possible mechanism

Am J Physiol 1997.272.R1734-R1739

39. Kriston T, R. Venuto, C. Baylis, Losonczy Gy:

The hemodynamic and renal effects of U 46 619 a
TXA2/PGH2 analog in late pregnant rats

Am J Physiol 1999. március (nyomdában)

40. Losonczy Gy, G. Brown, R.C. Venuto:

Pregnant or not pregnant - Systemic or pulmonary
hypertension induced by thromboxane A2 and deficiency of prostaglandins:
A hypothesis
Hypertension in Pregnancy 1996. 15. 281-85.

41. K. A. Louden, F. Broughton Pipkin, S.
Heptinstall, S. C. Fox, J. R. A. Mitchell, E. M. Symonds:

Platelet reactivity and serum thromboxane B2
production in whole blood in gestational hypertension and pre-eclampsia

Br J Obstet Gynecol 1991. 98. 1239-44.

42. M. Cervar, D. M. Nelson, F. Kainer, G. Desoye:

Drug actions in preeclampsia: Aspirin but not
magnesium chloride or dihydralazine, differentially inhibits cultured
human trophoblast release of thromboxane and prostacyclin without
affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

Am J Obstet Gynecol 1997. 176. 66-72.

43. Schiff, E. Peleg, M. Goldenberg, T. Rosenthal, E.
Ruppin, M. Tamarkin, G. Barkai, G. Ben-Baruch, I. Yahal, J. Blankstein,
B. Goldman, S. Mashiach:

The use of aspirin to prevent pregnancy-induced
hypertension and lower the ratio of thromboxane A2 to prostacyclin in
relatively high risk pregnancies

N Engl J Med 1989. 321. 351-56.

44. R. J. Clarke, G. Mayo, P. Price, G. A.
Fitzgerald:

Suppression of thromboxane A2 but not of systemic
prostacyclin by controlled-release aspirin

N Engl J Med 1991. 325. 1137-41.

45. S. Caritis, B. Sibai, J. Hauth, M. D. Lindheimer,
M. Lebanoff, E. Thom, P vanDorsten, M. Landon, R. Paul, M. Miodovnik, P.
Meis, G. Thurnau:

Low-dose aspirin to prevent preeclampsia in women at
high risk

N Engl J Med 1998. 338. 701-05.

46. C. Baylis, E. Beinder, T. Süto, P. August:

Recent insights into the roles of nitric oxide and
renin-angiotensin in the pathophysiology of preeclamptic pregnancy

Seminars in nephrology 1998. 18. 208-30.

47. S. P. Seligman, J. P. Buyon, R. M. Clancy, B. K.
Young, S. B. Abramson:

The role of nitric oxide in the pathogenesis of
preeclampsia

Am J Obstet Gynecol 1994. 171. 944-48.

48. Molnár M, F. Hertelendy:

N-nitro-L-arginin, an inhibitor of nitric oxide
synthesis, increases blood pressure in rats and reverses the
pregnancy-induced refractoriness to vasopressor agents

Am J Obstet Gynecol 1992. 166. 1560-1567.

49. Losonczy Gy, Mucha I, Müller V, Kriston T, Ungvári
Z, Tornóci L, Rosivall L, R. Venuto:

The vasoconstrictor effects of L-NAME, a nitric oxide
synthase inhibitor in pregnant rabbits

Br J Pharmacol 1996. 118. 1012-18.

50. K.P. Conrad, M. D. Mosher:

Nitric oxide biosynthesis in normal and pre-eclamptic
pregnancies. A preliminary report

J Am Soc Nephrol 1995. 6. 657.

51. S. L. Lubarsky, R. A. Ahokas, S. A. Friedman, B.
M. Sibai:

The effect of chronic nitric oxide synthesis
inhibition on blood pressure and angiotensin II responsiveness in the
pregnant rat

Am J Obstet Gynecol 1997. 176. 1069-76.

52. R. Arngrimsson, C. Hayward, S. Nadaud, et al:

Evidence for a familial pregnancy-induced hypertesion
locus in the eNOS-gene region

Am J Hum Genet 1997. 61. 354-62.

53. T. Krauss, W. Kuhn, C Lakoma, H. G. Augustin:

Circulating endothelial cell adhesion molecules as
diagnostic markers for the early identification of pregnant women at
risk for development of preeclampsia

Am J Obstet Gynecol 1997. 177. 443-49.

54. S. T. Davidge, A. P. Signorella, D. L. Lykins, c.
H. Gilmour, J. M. Roberts:

Evidence of endothelial activation and endothel
activators in cord blood of infants of preeclamptic women

Am J Obstet Gynecol 1996. 175. 1301-06.

55. J. M. Roberts, R. N. Taylor, T. J. Musci, G. M.
Rodgers, C. A. Hubel, M. K. McLaughlin:

Preeclampsia: An endothelial cell disorder

Am J Obstet Gynecol 1989. 161. 1200-04.

56. V. Rappaport, G. Hirata, H.K. Yap, S.C. Jordan:

Antivascular endothelial cell antibodies in severe
preeclampsia

Am J Obstet Gynecol 1990. 162.

57. F. Broughton Pipkin, C. Crowther, M. de Swiet, L.
Duley, R. J. Lilford, J. Onwude, C. Prentice, C. W. G. Redman, J.
Roberts, J Thornton, J. Walker:

Where next for prophylaxis against preeclampsia?

Br J Obstet Gynecol 1996. 103. 603-07.

58. D. A. McCarron, C. Morris, C. Cole:

Dietary calcium and human hypertension

Science 1982. 217. 267-69.

59. J. A. Prada, R. C. Tsang, K.E. Clark:

Hypocalcemia and pregnancy-induced hypertension
produced by low-calcium diet.

Hypertension 1994. 23. 695-702.

60. H. P. Schobel, T. Fischer, K. Heuszer, H. Geiger,
R. E. Schmieder:

Preeclampsia - A state of sympathetic overactivity

N Engl J Med 1996. 335. 1480-85.

61. E Schiff, S. A. Friedman, L. Kao, B. M. Sibai:

The importance of urinary protein excretion during
conservative management of severe preeclampsia

Am J Obstet Gynecol 1996. 175. 1313-16.

62. D. S. Dizon-Townson, L. M. Nelson, K. Easton, K.
Ward:

The factor V Leiden mutation may predispose women to
severe preeclampsia

Am J Obstet Gynecol 1996. 175. 902-05.

63. J. M. Roberts:

Preventing pre-eclampsia

Lancet 1996. 348. 281-82.

64. J. Bar, M. Hod, A. Erman, S. Friedman, I.
Gelerenter, B. Kaplan, G. Boner, J. Ovadia:

Microalbuminuria as an early predictor of
hypertensive complications in pregnant women at high risk

Am J Kidney Dis 1996. 28. 220-235.

65. H. Laivuori, R. Kaaja, E.-M. Rutanen, L Viinikka,
O. Ylikorkala:

Evidence of high circulating testosterone in women
with prior preeclampsia

J Clin Endocrinol Metab 1998. 83. 344-47.}